US doctors are unenthused about the reimbursement rates that private insurance companies pay. In a Medscape survey, they also say that staff need more time for paperwork. Medscape
Author: Medscape
Key Tips for Integrating New Ulcerative Colitis Therapies
Dr Jordan Axelrad discusses practical considerations for adding novel, targeted therapies in ulcerative colitis management. Medscape Gastroenterology
Time-Restricted Eating Is Not a Metabolic Magic Bullet
This lifestyle change wasn’t effective in reversing a lifestyle disease. Medscape
Eyelid Imaging Could Aid Early Diagnosis of Sjögren Disease
Patients with Sjögren disease had more damage to their oil-producing Meibomian glands than people with other varieties of dry eye. Medscape Medical News
Free Medical School Tuition Is Only Part of the Solution
Ethicist Art Caplan discusses free medical school tuition’s impact on growing number, diversity of primary care physicians. Medscape Business of Medicine
Infographic: Obesity Meds and AI Are Hot Topics
In a Medscape survey, expanded use of certain obesity medications, as well as artificial intelligence’s role in medical practice, proved concerning to doctors. Medscape
Diabetic Kidney Disease Therapies Keep on FLOWing
The FLOW study cements semaglutide’s position as a new therapeutic pillar for diabetic kidney disease, but what are its implications for primary care? Medscape Diabetes & Endocrinology
Cannabis Linked to Bulging Eyes in Graves’ Disease
Among patients with autoimmune hyperthyroidism, those who use cannabis were 1.9 times more likely to develop exophthalmos within 1 year of diagnosis. Medscape Medical News
Florida’s Federal Health Centers Failing Eye Care Needs
Only 8.9% Florida’s federally qualified health centers offered eye care services, far fewer than the estimated national average of 25%. Medscape Medical News
Parkinson’s Drug May Delay Onset of Wet AMD
L-dopa, a common Parkinson’s disease treatment, could reduce the burden of frequent injections for patients with wet AMD by delaying disease progression. Medscape Medical News
One in Three Pro Football Players Think They Have CTE
A stunning number of still-living former football players perceive chronic traumatic encephalopathy, with clinical implications. Medscape
McDonald Criteria Update Aims to Simplify, Speed MS Diagnosis
MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate. Medscape Medical News
Treating Family: Ethicist Discusses Whether It’s Appropriate
Ethicist Art Caplan discusses considerations for whether it’s ever appropriate to treat family or friends. Medscape Business of Medicine
Two New Drugs Approved for Age-Related Macular Degeneration
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its refusal of marketing authorization for Syfovre. Medscape Medical News
Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse
Adalimumab was superior to cyclosporine in preventing uveitis relapse in patients with severe Behçet disease already on corticosteroid therapy, according to randomized, open-label trial results. Medscape Medical News
Infographic: Frustration With Slow Progress on Resident Pay
Medical residents have had 2 straight years with decent pay gains. But because 7 lean years preceded that, they expressed frustration in a Medscape survey. Medscape
Coffee’s ‘Sweet Spot’: Consumption and Cardiometabolic Risk
How many daily cups of joe can be beneficial to health? Medscape
Rise of the Scribes
AI scribes will be ubiquitous soon. With their use, a doctor can — for the first time in a decade — turn from the glow of a screen to actually face the patient. Medscape Dermatology
Laughter: Comic Relief for Dry Eyes?
A little levity may bring relief to dry eyes, according to a new study, which found laughter therapy was as effective as eye drops in improving ocular surface disease index scores and tear film stability in patients with symptomatic dry eye disease. …
Biosimilar Matches Aflibercept for Diabetic Macular Edema
The new medication was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May. Medscape Medical News